Improving Sleep in BMT Survivors

Inclusion Criteria: FOR QUALITATIVE INTERVIEWS PRE-TEST * HCT survivors: Potentially eligible patients will be approached in person during a routine outpatient appointment at Moffitt Cancer Center or via telephone. * Additional eligibility criteria for HCT survivors will require that participants have undergone an allogeneic HCT within the previous 6 months - 2 years for a hematologic malignancy and be reporting clinically significant sleep disturbance (≥ 4 on a scale of 0 - 10). * Caregivers of HCT survivors: Patient participants will be asked to nominate and provide contact information for the person who was their primary caregiver before, during, or after their HCT hospitalization. * Adults ≥ 18 years old * Able to speak and read English * Able to provide informed consent * Have no documented or observable severe and untreated neurological or psychiatric disorders that would preclude participation (e.g., psychosis). * Clinicians: Eligible clinicians will be oncologists, nurses, or other clinicians at the Moffitt Cancer Center Blood and Marrow Transplant Program. FOR INTERVENTION GROUPS * Are ≥18 years of age * Have been diagnosed with a hematologic malignancy * Were discharged after allogeneic HCT within the previous 110 days (to allow for those who return to clinic within approximately 2 weeks of their planned 90-day clinic visit) * Are experiencing clinically significant sleep disturbance * Have never been diagnosed with nor are at high risk of sleep disorders that a…